Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SOF/VEL with Prophylactic TAF for HCV/HBV Co-infection
NCT04997564Phase 4Unknown
- Sponsor
- Peking University First Hospital
- Start
- Aug 2021
- Primary completion
- Dec 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of sofosbuvir + velpatasvir in hepatitis C virus infection, sponsored by Peking University First Hospital. Status: unknown.
02
Drugs
sofosbuvir + velpatasvir
03
Conditions
hepatitis C virus infection
Beyond the preview
Go deeper on NCT04997564.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04997564.